Walker Luke Nathaniel, SVP, Clinical Development at Cascadian Therapeutics, holds 0.00 shares in Cascadian Therapeutics (Ticker: CASC), holds ― shares in Harpoon Therapeutics (Ticker: HARP).
What is the percentage of profitable transactions made by Walker Luke Nathaniel?
The percentage of profitable transactions made by Walker Luke Nathaniel is ―.
What is the average return per transaction made by Walker Luke Nathaniel?
The average return per transaction made by Walker Luke Nathaniel is ―.
What stocks does Walker Luke Nathaniel hold?
Walker Luke Nathaniel holds: CASC, HARP stocks.
What was Walker Luke Nathaniel’s latest transaction?
Walker Luke Nathaniel latest transaction was an Uninformative Sell of ―.
What was Walker Luke Nathaniel's most profitable transaction?
Walker Luke Nathaniel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Walker Luke Nathaniel's role in Cascadian Therapeutics?
Walker Luke Nathaniel's role in Cascadian Therapeutics is SVP, Clinical Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.